Lixelle Beta 2-microglobulin Apheresis Column authorized for use in DRA
Three doses of testosterone nasal gel may help normalize testosterone levels in men with hypogonadism.
Even if the needle is changed, diabetes pens may harbor traces of blood on other parts.
Prescription testosterone product labels must now include warnings about the possible increased risk of heart attacks and strokes, says FDA.
The U.S. Food and Drug Administration has approved the first weight loss treatment device, the Maestro Rechargeable System by EnteroMedics of St. Paul, Minnesota.
Combo Zerbaxa is sanctioned for complicated intra-abdominal and urinary tract infections
Targeted pathogens include AIDS-causing HIV, hepatitis B and C, and the West Nile virus
NBI visualized non-muscle-invasive bladder cancer lesions in 17% more patients and 24% more tumors than white light.
Once-weekly subcutaneous injection of Trulicity (dulaglutide), a glucagon-like peptide-1 receptor agonist.
Blocks reabsorption of glucose by kidneys.
The product is self-administered via a nasal applicator.
FDA clears albiglutide as an adjunct to diet and exercise for glycemic control in adult type 2 diabetes patients.
Astellus Pharma and Medivation ask the FDA to approve enzalutamide as a treatment for advanced prostate cancer in chemotherapy-naïve men.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)